LLY Q3 2022 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q3 2022 Earnings

Reported November 1, 2022

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2022	Q2 2022	Q3 2021	QoQ Change	YoY Change
Revenue	$6.9B	$6.5B	$6.8B	7.0%	2.5%
Op. Income	$2.0B	$1.7B	$2.1B	16.8%	-4.4%
Gross Margin	77.3%	78.0%	78.9%	-0.7pp	-1.6pp
Net Margin	20.9%	14.7%	16.4%	6.2pp	4.5pp
EPS (Diluted)	$1.61	$1.05	$1.16	53.3%	38.8%
Free Cash Flow	$1.6B	$370M	$1.2B	323.2%	33.1%

Revenue Flow

Item	Amount
REVENUE	$6.9B
Cost of Revenue	$1.6B
GROSS PROFIT	$5.4B
R&D Expenses	$1.8B
Selling & Marketing	$0
General & Administrative	$1.5B
SG&A Expenses	$1.5B
Other Expenses	$0
Operating Expenses	$3.3B
Cost & Expenses	$4.9B
OPERATING INCOME	$2.0B
Interest Income	$20M
Interest Expense	$82M
Other Income/Expenses	-$472M
INCOME BEFORE TAX	$1.6B
Income Tax Expense	$114M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$363M
EBIT	$1.6B
EBITDA	$2.0B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$6.9B
Cost of Revenue	$1.6B
GROSS PROFIT	$5.4B
R&D Expenses	$1.8B
Selling & Marketing	$0
General & Administrative	$1.5B
SG&A Expenses	$1.5B
Other Expenses	$0
Operating Expenses	$3.3B
Cost & Expenses	$4.9B
OPERATING INCOME	$2.0B
Interest Income	$20M
Interest Expense	$82M
Other Income/Expenses	-$472M
INCOME BEFORE TAX	$1.6B
Income Tax Expense	$114M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$363M
EBIT	$1.6B
EBITDA	$2.0B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$1.5B
Depreciation & Amortization	$363M
Stock-Based Compensation	$85M
Deferred Income Tax	-$1.1B
Other Non-Cash Items	$460M
Change in Working Capital	$928M
OPERATING CASH FLOW	$2.2B
Capital Expenditure	-$652M
Acquisitions (Net)	$0
Purchases of Investments	-$255M
Sales/Maturities of Investments	$109M
Other Investing Activities	-$192M
NET CASH FROM INVESTING	-$955M
Net Debt Issuance	-$376M
Common Stock Repurchased	$0
Common Dividends Paid	-$882M
Other Financing Activities	-$5M
NET CASH FROM FINANCING	-$1.3B
FREE CASH FLOW	$1.6B
Net Change in Cash	-$6M

Balance Sheet

Item	Amount
Cash & Equivalents	$2.6B
Short-Term Investments	$125M
Net Receivables	$8.3B
Inventory	$3.8B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$17.6B
PP&E (Net)	$9.3B
Goodwill	$3.9B
Intangible Assets	$7.1B
Long-Term Investments	$2.6B
Tax Assets	$2.4B
Other Non-Current Assets	$4.5B
TOTAL NON-CURRENT ASSETS	$29.8B
TOTAL ASSETS	$47.5B
Account Payables	$1.7B
Short-Term Debt	$1.7B
Deferred Revenue	$0
Other Current Liabilities	$10.6B
TOTAL CURRENT LIABILITIES	$15.7B
Long-Term Debt	$14.1B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$172M
Other Non-Current Liabilities	$7.3B
TOTAL NON-CURRENT LIABILITIES	$21.6B
TOTAL LIABILITIES	$37.3B
Common Stock	$594M
Additional Paid-In Capital	$6.8B
Retained Earnings	$10.0B
Treasury Stock	-$51M
Accum. Other Comp. Income	-$4.3B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$10.1B
Minority Interest	$96M
TOTAL EQUITY	$10.2B
TOTAL LIABILITIES & EQUITY	$47.5B
Total Debt	$15.9B
Net Debt	$13.3B